Total Synthesis of the Proposed Structure for Itralamide B

Xiaoji Wang; Chanshan Lv; Junyang Liu; Linjun Tang; Junmin Feng; Shoubin Tang; Zhuo Wang; Yuqing Liu; Yi Meng; Tao Ye; Zhengshuang Xu

doi:10.1055/s-0033-1340872

Synlett, Table of Contents

Synlett 2014; 25(07): 1014-1018
DOI: 10.1055/s-0033-1340872

letter

Total Synthesis of the Proposed Structure for Itralamide B

Authors

Xiaoji Wang*

^aSchool of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang, 330013, P. R. of China Email: professorwxj@163.com
Chanshan Lv

^aSchool of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang, 330013, P. R. of China Email: professorwxj@163.com

^bLaboratory of Chemical Genomics, Peking University Shenzhen Graduate School, University Town of Shenzhen, Xili, Nanshan District, Shenzhen, 518055, P. R. of China Email: xuzs@pkusz.edu.cn
Junyang Liu

^bLaboratory of Chemical Genomics, Peking University Shenzhen Graduate School, University Town of Shenzhen, Xili, Nanshan District, Shenzhen, 518055, P. R. of China Email: xuzs@pkusz.edu.cn

^cDepartment of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Fax: +85222641912 Email: tao.ye@polyu.edu.hk
Linjun Tang

^aSchool of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang, 330013, P. R. of China Email: professorwxj@163.com
Junmin Feng

^aSchool of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang, 330013, P. R. of China Email: professorwxj@163.com
Shoubin Tang

^bLaboratory of Chemical Genomics, Peking University Shenzhen Graduate School, University Town of Shenzhen, Xili, Nanshan District, Shenzhen, 518055, P. R. of China Email: xuzs@pkusz.edu.cn
Zhuo Wang

^cDepartment of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Fax: +85222641912 Email: tao.ye@polyu.edu.hk
Yuqing Liu

^cDepartment of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Fax: +85222641912 Email: tao.ye@polyu.edu.hk
Yi Meng

^bLaboratory of Chemical Genomics, Peking University Shenzhen Graduate School, University Town of Shenzhen, Xili, Nanshan District, Shenzhen, 518055, P. R. of China Email: xuzs@pkusz.edu.cn
Tao Ye*

^cDepartment of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Fax: +85222641912 Email: tao.ye@polyu.edu.hk
Zhengshuang Xu*

^aSchool of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang, 330013, P. R. of China Email: professorwxj@163.com

^bLaboratory of Chemical Genomics, Peking University Shenzhen Graduate School, University Town of Shenzhen, Xili, Nanshan District, Shenzhen, 518055, P. R. of China Email: xuzs@pkusz.edu.cn

Abstract

All articles of this category

Abstract

A stereocontrolled total synthesis of the cyclodepsipeptide, itralamide B, has been achieved. Both R- and S-stereoisomers of the side chain were attached to the macrocyclic ring, however, the synthesized structure appears to be different from that of the marine natural product.

Key words

natural products - total synthesis - macrolactonization - configuration determination - stereoselectivity

Full Text

References

References and Notes
1 Lemmens-Gruber R, Kamyar MR, Dornetshuber R. Curr. Med. Chem. 2009; 16: 1122
2 Suyama TL, Gerwick WH, McPhail KL. Bioorg. Med. Chem. 2011; 19: 6675

3a Liu H, Liu Y, Wang Z, Xing X, Maguire AR, Luesch H, Zhang H, Xu Z, Ye T. Chem. Eur. J. 2013; 19: 6774
3b Long B, Tang S, Chen L, Qu S, Chen B, Liu JY, Maguire AR, Wang Z, Liu Y, Zhang H, Xu ZS, Ye T. Chem. Commun. 2013; 49, 2977
3c Boyaud F, Mahiout Z, Lenoir C, Tang S, Wdzieczak-Bakala J, Witczak A, Bonnard I, Banaigs B, Ye T, Inguimbert N. Org. Lett. 2013; 15: 3898
3d Wang L, Xu Z, Ye T. Org. Lett. 2011; 13: 2506
3e Liu H, Liu YQ, Xu ZS, Ye T. Chem. Commun. 2010; 46: 7486
3f Liang S, Xu ZS, Ye T. Chem. Commun. 2010; 46: 153
3g Li S, Liang S, Tan WF, Xu ZS, Ye T. Tetrahedron 2009; 65: 2695
3h Ren Q, Dai L, Zhang H, Tan W, Xu ZS, Ye T. Synlett 2008; 2379
3i Pang HW, Xu ZS, Ye T. Lett. Org. Chem. 2005; 2: 703
3j Chen HL, Xu ZS, Ye T. Tetrahedron 2005; 61: 11132
3k Chen ZY, Deng JG, Ye T. ARKIVOC 2003; (vii): 268

4a Dai L, Chen B, Lei H, Wang Z, Liu Y, Xu Z, Ye T. Chem. Commun. 2012; 48: 8697
4b Liu J, Ma X, Liu Y, Wang Z, Kwong S, Ren Q, Tang S, Meng Y, Xu Z, Ye T. Synlett 2012; 783
4c Gao XG, Liu YQ, Kwong SQ, Xu ZX, Ye T. Org. Lett. 2010; 12: 3018
4d Chen B, Dai L, Zhang H, Tan W, Xu ZS, Ye T. Chem. Commun. 2010; 46: 574
4e Li S, Liang S, Xu ZS, Ye T. Synlett 2008; 569
4f Peng YG, Pang HW, Ye T. Org. Lett. 2004; 6: 3781
4g Xu ZS, Peng YG, Ye T. Org. Lett. 2003; 5: 2821

5 Jiménez JI, Vansach T, Yoshida WY, Sakamoto B, Pörzgen P, Horgen FD. J. Nat. Prod. 2009; 72: 1573
6 Bhushan R, Brückner H. Amino Acids 2004; 27: 231
7 Medina RA, Goeger DE, Hills P, Mooberry SL, Huang N, Romero LI, Ortega-Barria E, Gerwick WH, McPhail KL. J. Am. Chem. Soc. 2008; 130: 6324
8 Ford PW, Gustafson KR, McKee TC, Shigematsu N, Maurizi LK, Pannell LK, Williams DE, Dilip de Silva E, Lassota P, Allen TM, Van Soest R, Andersen RJ, Boyd MR. J. Am. Chem. Soc. 1999; 121: 5899
9 Ridley CP, Bergquist PR, Harper MK, Faulkner DJ, Hooper JN, Haygood MG. Chem. Biol. 2005; 12: 397

Lyngbyabellin A was isolated from marine cyanobacterium Lyngbya majuscule, see:

10a Luesch H, Yoshida WY, Moore RE, Paul VJ, Mooberry SL. J. Nat. Prod. 2000; 63: 611

Its structure and absolute stereochemistry were confirmed by total syntheses, see:

10b Pang HW, Xu ZS, Chen ZY, Ye T. Lett. Org. Chem. 2005; 2: 699
10c Yokokawa F, Sameshima H, Shioiri T. Tetrahedron Lett. 2001; 42: 4171

11 Jin Y, Liu YQ, Wang Z, Kwong S, Xu ZS, Ye T. Org. Lett. 2010; 12: 1100
12 All the attempts to close the macrocycle by macrolactamization met with failure. The detailed studies will be reported in due course.

13a Taniguchi A, Sohma Y, Kimura M, Okada T, Ikeda K, Hayashi Y, Kimura T, Hirota S, Matsuzaki K, Kiso Y. J. Am. Chem. Soc. 2006; 128: 696
13b Coin I, Dölling R, Krause E, Bienert M, Beyermann M, Sferdean CD, Carpino LA. J. Org. Chem. 2006; 71: 6171
13c Yoshiya T, Sohma Y, Kimura T, Hayashi Y, Kiso Y. Tetrahedron Lett. 2006; 47: 7905
13d Sohma Y, Taniguchi A, Skwarczynski M, Yoshiya T, Fukao F, Kimura T, Hayashi Y, Kiso Y. Tetrahedron Lett. 2006; 47: 3013
13e Sohma Y, Hayashi Y, Kimura M, Chiyomori Y, Taniguchi A, Sasaki M, Kimura T, Kiso Y. J. Pept. Sci. 2005; 11: 441
13f Sohma Y, Sasaki M, Hayashi Y, Kimura T, Kiso Y. Chem. Commun. 2004; 124
13g Mouls L, Subra G, Enjalbal C, Martinez J, Aubagnac J.-L. Tetrahedron Lett. 2004; 45: 1173
13h Horikawa M, Shigeri Y, Yumoto N, Yoshikawa S, Nakajima T, Ohfune Y. Bioorg. Med. Chem. Lett. 1998; 8: 2027
13i Seo H, Lim D. J. Org. Chem. 2009; 74: 906
13j Lécaillon J, Gilles P, Subra G, Martinez J, Amblard M. Tetrahedron Lett. 2008; 49: 4674
13k Stawikowski M, Cudic P. Tetrahedron Lett. 2006; 47: 8587
13l Durette PL, Baker F, Barker PL, Boger J, Bandy SS, Hammond ML, Lanza TJ, Pessolano AA, Caldwell CG. Tetrahedron Lett. 1990; 31: 1237
13m Mauger AB, Stuart OA. Int. J. Pept. Protein Res. 1987; 30: 481

14 Evans DA, Wu LD, Wiener JJ. M, Johnson JS, Ripin DH. B, Tedrow JS. J. Org. Chem. 1999; 64: 6411
15 Lapatsanis L, Milias G, Paraskewas S. Synthesis 1985; 513
16 Rodríguez-Escrich C, Urpí F, Vilarrasa J. Org. Lett. 2008; 10: 5191
17 De Luca L, Giacomelli G, Porcheddu A. Org. Lett. 2001; 3: 3041

18a Spaggiari A, Vaccari D, Davoli P, Torre G, Prati F. J. Org. Chem. 2007; 72: 2216
18b Gao S, Wang Q, Chen C. J. Am. Chem. Soc. 2009; 131: 1410

19 White KN, Konopelski JP. Org. Lett. 2005; 7: 4111

20a Carpino LA. J. Am. Chem. Soc. 1993; 115: 4397
20b Carpino LA, Imazumi H, El-Faham A, Ferrer FJ, Zhang C, Lee Y, Foxman BM, Henklein P, Hanay C, Mügge C, Wenschuh H, Klose J, Beyermann M, Bienert M. Angew. Chem. Int. Ed. 2002; 41: 441

21 Albericio F, Cases M, Alsina J, Triolo SA, Carpino LA, Kates SA. Tetrahedron Lett. 1997; 38: 4853

22a Tung RD, Rich DH. J. Am. Chem. Soc. 1985; 107: 4343
22b Tung RD, Rich DH. J. Org. Chem. 1986; 17: 3351

23 Evans EF, Lewis NJ, Kapfer I, Macdonald G, Taylor RJ. K. Synth. Commun. 1997; 27: 1819
24 Shiina I, Kubota M, Oshiumi H, Hashizume M. J. Org. Chem. 2004; 69: 1822
25 Synthesis of Itralamide B (1): Compound 18 (23.0 mg, 0.03 mmol, 1.0 equiv) was dissolved in CH₂Cl₂ (1.0 mL) at 0 °C, and BF₃·OEt₂ (34 μL, 0.3 mmol, 10.0 equiv) was added dropwise to the solution at 0 °C. The reaction solution was allowed to warm to r.t. and stirred for 0.5–1.0 h (reaction monitored by TLC). The reaction was quenched by the addition of saturated NH₄Cl (2 mL) and diluted with CH₂Cl₂ (60 mL). The organic phase was washed with saturated NH₄Cl (3 × 20 mL) and brine (20 mL), dried over anhydrous Na₂SO₄ and concentrated in vacuo to afford the crude hydroxy acid. A solution of this hydroxy acid in THF–PhMe (10 mL, 1:1) was slowly added to a solution of DMAP (33 mg, 0.3 mmol, 10.0 equiv) and MNBA (47 mg, 0.14 mmol, 5.0 equiv) in PhMe (10 mL) at 0 °C. The reaction mixture was warmed to r.t., then stirred and heated to 60 °C for 2 d. The reaction mixture was diluted with EtOAc (100 mL) and washed successively with saturated NH₄Cl (3 × 20 mL) and brine (2 × 20 mL), dried over anhydrous Na₂SO₄, and concentrated in vacuo. The residue was purified by flash chromatography (EtOAc) to afford (S)-itralamide B (1; 5.0 mg, 21%). (S)-Itralamide B (1): [α]_D ²⁵ –44.63 (c 0.4, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 7.45–7.12 (m, 5 H), 6.90 (d, J = 9.6 Hz, 1 H), 6.47 (d, J = 8.0 Hz, 1 H), 5.99 (d, J = 2.9 Hz, 1 H), 5.75–5.65 (m, 2 H), 5.53–5.43 (m, 1 H), 5.08 (q, J = 6.8 Hz, 1 H), 4.98 (dd, J = 7.9, 4.2 Hz, 1 H), 4.71 (dd, J = 9.4, 4.1 Hz, 1 H), 4.62 (q, J = 7.6 Hz, 1 H), 3.66 (dd, J = 15.5, 4.9 Hz, 1 H), 3.33 (d, J = 23.6 Hz, 3 H), 3.19 (d, J = 7.1 Hz, 3 H), 3.17–3.07 (m, 3 H), 3.07–2.94 (m, 3 H), 2.87 (dd, J = 15.6, 12.1 Hz, 1 H), 2.80 (d, J = 4.0 Hz, 1 H), 2.76–2.65 (m, 1 H), 2.46 (dd, J = 16.5, 7.5 Hz, 1 H), 2.28–2.21 (m, 1 H), 2.06–1.99 (m, 1 H), 1.29 (d, J = 2.0 Hz, 3 H), 1.26 (d, J = 2.8 Hz, 3 H), 1.20 (dd, J = 6.6, 3.5 Hz, 3 H), 1.08–1.01 (m, 6 H), 0.92 (dd, J = 9.4, 7.2 Hz, 6 H), 0.80 (d, J = 6.8 Hz, 3 H); ¹³C NMR (100 MHz, CDCl₃): δ = 174.89, 172.84, 172.53, 170.65, 170.17, 169.90, 169.47, 137.35, 128.54, 128.34, 126.48, 78.18, 69.62, 56.92, 56.75, 54.69, 54.68, 53.98, 51.43, 40.65, 35.75, 33.92, 33.77, 32.15, 31.83, 31.12, 31.00, 30.54, 19.90, 19.63, 17.82, 17.10, 15.61, 15.35, 14.10, 13.82. HRMS (ESI): m/z [M+Na]⁺ calcd for C₃₈H₅₈Cl₂N₆NaO₈ ⁺: 819.3585; found: 819.3587. (R)-Itralamide B (1): [α]_D ²⁵ –42.33 (c 0.2, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 7.24–7.16 (m, 5 H), 6.89 (d, J = 9.1 Hz, 1 H), 6.48 (d, J = 7.8 Hz, 1 H), 6.04 (d, J = 2.9 Hz, 1 H), 5.78–5.63 (m, 1 H), 5.49 (dd, J = 6.6, 3.2 Hz, 1 H), 5.45–5.35 (m, 1 H), 5.12–5.02 (m, 1 H), 4.98 (dd, J = 7.8, 4.2 Hz, 1 H), 4.71 (dd, J = 9.3, 4.0 Hz, 1 H), 4.67–4.55 (m, 1 H), 3.66 (dd, J = 15.3, 5.1 Hz, 1 H), 3.28 (d, J = 63.9 Hz, 3 H), 3.18 (s, 3 H), 3.13 (d, J = 23.1 Hz, 3 H), 3.01 (d, J = 11.3 Hz, 3 H), 2.93 (d, J = 15.7 Hz, 1 H), 2.90–2.78 (m, 1 H), 2.78–2.67 (m, 1 H), 2.43 (dd, J = 16.7, 6.0 Hz, 1 H), 2.25 (dd, J = 11.9, 5.9 Hz, 1 H), 2.04 (d, J = 9.5 Hz, 1 H), 1.38 (dd, J = 18.4, 7.2 Hz, 3 H), 1.30 (d, J = 6.7 Hz, 3 H), 1.20 (d, J = 6.6 Hz, 3 H), 1.06 (d, J = 6.8 Hz, 6 H), 0.92 (dd, J = 11.7, 7.0 Hz, 6 H), 0.80 (d, J = 6.8 Hz, 3 H); ¹³C NMR (100 MHz, CDCl₃): δ = 174.88, 172.83, 172.56, 170.68, 170.17, 169.85, 169.51, 137.37, 128.55, 128.34, 126.48, 78.02, 69.64, 56.88, 56.75, 54.75, 54.22, 53.99, 51.47, 40.45, 35.98, 33.97, 33.78, 32.18, 31.85, 31.12, 31.02, 30.55, 19.89, 19.63, 17.82, 17.09, 17.07, 15.60, 15.05, 13.83 ppm. HRMS (ESI): m/z [M+Na]⁺ for C₃₈H₅₈Cl₂N₆NaO₈ ⁺: 819.3585; found: 819.3589.
26 See the Supporting Information for detailed analyses.

Supplementary Material

Supporting Information (PDF)